EndoTheia, Inc., a leader in innovative surgical technology, is pleased to announce the successful completion of the first-in-human clinical trial for the FlexStone™ Basket, the first-ever ...
SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
SonoMotion, a medical device company developing non-invasive solutions for kidney stones, announced today that the FDA has granted de novo clearance for the Company's Stone Clear™ device for the ...
First and only device using non-invasive ultrasound pulses to facilitate passage of kidney stone fragments post-lithotripsy Kidney stones affect one in 10 people in the US, costing $10 billion ...